• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/088 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/088

Total number of patents in this class: 446

10-year publication summary

32
31
24
30
35
29
22
29
30
6
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Alkermes Pharma Ireland Limited
256
14
Corsair Pharma, Inc.
37
14
FUJIFILM Corporation
30126
11
The University of British Columbia
1537
10
Dow Global Technologies LLC
10740
9
Novartis AG
10463
8
British Columbia Cancer Agency Branch
185
8
The United States of America, as represented by the Secretary, Department of Health and Human Services
2958
7
BASF SE
21131
6
The Scripps Research Institute
1342
6
Gotion Inc.
39
6
Translate bio, Inc.
415
6
Sumitomo Chemical Company, Limited
9064
5
Board of Regents, The University of Texas System
6028
5
The Trustees of Columbia University in the City of New York
3614
5
Emory University
1691
5
Wave Life Sciences Ltd.
196
5
Sanofi
4164
5
Cassava Science, Inc.
13
5
Merck Patent GmbH
5741
4
Other owners 302